Black Diamond Therapeutics, Inc. (BDTX) Insider Trading

Name: Black Diamond Therapeutics, Inc. (BDTX) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Sep 21, 2026): Ali Behbahani (Director): Grant/Award of 7,707 shares, $14.9K.

Get alerted when insiders trade BDTX

Every alert includes an AI-written analysis of the filing, plus news and market context.

Email address

Loading company data...

Beta

Loading company details...

Beta